Fluosphera: in-vitro drug screening platform mimicking systemic conditions delivering reliable efficacy and safety data while reducing animal use
Gesamtkosten:
CHF1,109,625.80
Beteiligte
(Contact person)- FluoSphera SA
- www.umwelt-schweiz.ch/technologiefoerderung
- FluoSphera SA
- www.umwelt-schweiz.ch/technologiefoerderung
- EPFL - Ecole Polytechnique Fédérale
- de Lausanne
- Université de Genève
Abstract
Key words
Abstract